Bridge financing agreements fund a company's operations until it can arrange a more comprehensive longer-term financing. The need for a bridge loan arises when a company runs out of cash before it can obtain more capital investment through long-term debt or equity. Laidlaw provided bridge financing to a video surveillance technology company for working capital to sustain its growth during the lengthy period prior to completing an IPO. And when a biotech company with an orphan drug long proven in Europe but not yet authorized for marketing in the US, came to us for private equity financing via a reverse merger into a PIPE-eligible company, we identified an IPO as a preferable financing path. Laidlaw led a pre-IPO equity round that provided the client liquidity needed to commence its FDA Phase III Trial and bridge the time needed to complete the IPO.

For more information, contact Hugh Regan at HRegan@laidlawltd.com, or call (212) 697-5200.